Brochure | March 3, 2022

Isotope Labelling

Source: Quotient Sciences
GettyImages-1295492925-computer-future-data-research-lab

Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.

With over 30 years of successful delivery on-site, Quotient Sciences' highly trained chemists have extensive chemical and radiochemical knowledge and the experience required to supply consultancy and advice on the most suitable labelling positions for a variety of molecular entities.

Trust us to deliver on time in, in full – 98% delivery rate at Quotient

We pride ourselves on accelerating your drug compounds to the clinic. Our team of experts provide guidance on the design and conduct of both non-clinical and clinical human ADME studies for research, development and regulatory purposes. Our radiolabelling expertise is available as a standalone service or as part of our integrated Synthesis-to-Clinic™ offering. Customers who have placed both their non-clinical and clinical studies with us, have shortened their time to clinic and saved on development costs by avoiding the need for re-synthesis.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma